TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Nadim Akhtar, PhD
Principal Scientist at AstraZeneca

Profile

Nadim has a PhD degree in chemistry from Manchester and has been working for AstraZeneca since 2005. During this time Nadim has worked across different fields including separation science, New modalities (proteins, peptides, nucleic acids and nanomedicines) and Predictive Science supporting both drug substance and drug product activities. Nadim currently sits in the Global Product Development. Nadim has worked in the oligonucleotide area for just over 6 years, focusing on both early and late stage portfolio. Nadim has been involved with several regulatory filing for small molecules, oligonucleotides and nanomedicines.

Nadim Akhtar, PhD's Network

Agenda Sessions

  • Chairperson's Remarks

    , 13:50
  • Strategies for Identity Testing of Oligonucleotide Therapeutics

    , 16:00